Title:
癌細胞を標的とする遺伝子の伝達方法
Document Type and Number:
Japanese Patent JP4459964
Kind Code:
B2
Abstract:
The inventive chimeric ligand in the form of a fusion polypeptide of a single-chain antibody specific for Tag-72 surface antigen and GaLV envelope glycoprotein shows high transduction efficiency to cancer cells, specifically infects target cells and efficiently delivers a therapeutic gene. Accordingly, the inventive chimeric ligand can be effectively used for gene therapy to inhibit tumor growth and metastasis.
More Like This:
Inventors:
Kim Young Seo
Seo Insop
Lee Young Kwan
Kim Jong Pill
Kang Monkyun
Hong Hyo Jung
Seo Insop
Lee Young Kwan
Kim Jong Pill
Kang Monkyun
Hong Hyo Jung
Application Number:
JP2006539363A
Publication Date:
April 28, 2010
Filing Date:
March 15, 2004
Export Citation:
Assignee:
INJE UNIVERSITY
International Classes:
C07K19/00; C12N15/09; A61K38/00; A61P35/00; C07K14/15; C07K16/30; C12N5/10; C12N7/00; C12N15/867
Other References:
Dingli D. et al., Genetic targeting of retroviral vectors, Mar. 2003,p.267-291
Int. J. Cancer, 2001, Vol.94, p.717-726
Virology, 2000, Vol.269, p.7-17
The Journal of Gene Medicine, 1999, Vol.1, p.300-311
Int. J. Cancer, 2001, Vol.94, p.717-726
Virology, 2000, Vol.269, p.7-17
The Journal of Gene Medicine, 1999, Vol.1, p.300-311
Attorney, Agent or Firm:
Kyousei Tamura
Nagatoshi Shinagawa
Nagatoshi Shinagawa